AT-33 A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME

Por Krauze, Andra V., Myrehaug, Sten D., Chang, Michael G., Holdford, Diane J., Smith, Sharon, Shih, Joanna, Tofilon, Peter, Fine, Howard, Camphausen, Kevin A.
Publicado em 2014

ACTR-57. DOES THE ADDITION OF VALPROIC ACID TO CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IMPROVE PATIENT OUTCOME? – CORRELATIVE ANALYSIS OF RTOG 0525, SEER AND A PHASE II NCI T...

Por Krauze, Andra, Myrehaug, Sten, Chang, Michael, Holdford, Diane, Smith, Sharon, Shih, Joanna, Tofilon, Philip, Fine, Howard, Rowe, Lindsay, Gilbert, Mark R, Camphausen, Kevin
Publicado no Neuro Oncol (2017)

A Phase 2 Study of Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid For Patients With Glioblastoma

Por Krauze, Andra V., Myrehaug, Sten D., Chang, Michael G., Holdford, Diane J., Smith, Sharon, Shih, Joanna, Tofilon, Philip J., Fine, Howard A., Camphausen, Kevin
Publicado no Int J Radiat Oncol Biol Phys (2015)

A Phase II Study to Prevent Radiation-Induced Rectal Injury with Lovastatin

Por Anscher, Mitchell S., Chang, Michael G., Moghanaki, Drew, Rosu, Mihaela, Mikkelsen, Ross B., Holdford, Diane, Skinner, Vicki, Grob, B. Mayer, Sanyal, Arun, Wang, Aiping, Mukhopadhyay, Nitai D.
Publicado no Am J Clin Oncol (2018)